Paloma Partners’s State Street Health Care Select Sector SPDR ETF XLV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-59,000
| Closed | -$8.12M | – | 275 |
|
|
2024
Q4 | $8.12M | Buy |
59,000
+28,900
| +96% | +$4.23M | 0.36% | 52 |
|
|
2024
Q3 | $4.64M | Sell |
30,100
-88,200
| -75% | -$13.4M | 0.13% | 154 |
|
|
2024
Q2 | $17.2M | Buy |
118,300
+17,458
| +17% | +$2.5M | 0.49% | 28 |
|
|
2024
Q1 | $14.9M | Buy |
100,842
+23,842
| +31% | +$3.42M | 0.79% | 18 |
|
|
2023
Q4 | $10.5M | Buy |
77,000
+25,100
| +48% | +$3.27M | 0.38% | 36 |
|
|
2023
Q3 | $6.68M | Buy |
51,900
+18,900
| +57% | +$2.51M | 0.23% | 75 |
|
|
2023
Q2 | $4.38M | Buy |
33,000
+31,200
| +1,733% | +$4.11M | 0.16% | 124 |
|
|
2023
Q1 | $233K | Sell |
1,800
-16,500
| -90% | -$2.16M | 0.01% | 599 |
|
|
2022
Q4 | $2.49M | Buy |
18,300
+9,800
| +115% | +$1.3M | 0.11% | 166 |
|
|
2022
Q3 | $1.03M | Sell |
8,500
-14,100
| -62% | -$1.82M | 0.05% | 318 |
|
|
2022
Q2 | $2.9M | Buy |
22,600
+15,600
| +223% | +$2.04M | 0.1% | 190 |
|
|
2022
Q1 | $959K | Buy |
7,000
+6,000
| +600% | +$794K | 0.03% | 458 |
|
|
2021
Q4 | $141K | Buy |
+1,000
| New | +$133K | ﹤0.01% | 1700 |
|
|
2020
Q2 | – | Sell |
-15,300
| Closed | -$1.36M | – | 2269 |
|
|
2020
Q1 | $1.36M | Buy |
+15,300
| New | +$1.49M | 0.08% | 217 |
|
|
2019
Q4 | – | Sell |
-13,000
| Closed | -$1.17M | – | 2561 |
|
|
2019
Q3 | $1.17M | Hold |
13,000
| – | – | 0.02% | 662 |
|
|
2019
Q2 | $1.2M | Buy |
13,000
+6,000
| +86% | +$539K | 0.02% | 625 |
|
|
2019
Q1 | $642K | Sell |
7,000
-76,600
| -92% | -$6.91M | 0.02% | 945 |
|
|
2018
Q4 | $7.23M | Buy |
83,600
+34,600
| +71% | +$3.13M | 0.22% | 64 |
|
|
2018
Q3 | $4.66M | Buy |
+49,000
| New | +$4.43M | 0.08% | 200 |
|
|
2018
Q1 | – | Sell |
-110,000
| Closed | -$9.1M | – | 2302 |
|
|
2017
Q4 | $9.1M | Sell |
110,000
-1,500
| -1% | -$124K | 0.12% | 136 |
|
|
2017
Q3 | $9.11M | Buy |
+111,500
| New | +$8.95M | 0.13% | 137 |
|
|
2017
Q2 | – | Sell |
-73,900
| Closed | -$5.5M | – | 2480 |
|
|
2017
Q1 | $5.5M | Sell |
73,900
-600
| -0.8% | -$43.7K | 0.07% | 271 |
|
|
2016
Q4 | $5.14M | Buy |
+74,500
| New | +$5.17M | 0.05% | 248 |
|
|
2016
Q3 | – | Sell |
-28,000
| Closed | -$2.01M | – | 2168 |
|
|
2016
Q2 | $2.01M | Buy |
+28,000
| New | +$1.97M | 0.02% | 714 |
|
|
2016
Q1 | – | Sell |
-245,300
| Closed | -$17.7M | – | 2101 |
|
|
2015
Q4 | $17.7M | Buy |
+245,300
| New | +$17.3M | 0.47% | 26 |
|
Other funds holding XLV
NAM
Paloma Partners's XLV Position: Q3 2025 in Review
Paloma Partners sold out of State Street Health Care Select Sector SPDR ETF (XLV) in Q3 2025, closing a stake of 31,175 shares — an estimated $4.2M sold.
Paloma Partners first reported a position in XLV in Q3 2014 and held it in 39 quarters. The position peaked at $65.5M in Q2 2019. 1,647 funds tracked by Wall St. Rank hold XLV as of Q3 2025.
- Paloma Partners reported no remaining State Street Health Care Select Sector SPDR ETF position as of Q3 2025 after selling out during the quarter.
- Paloma Partners sold 31,175 State Street Health Care Select Sector SPDR ETF shares in Q3 2025, an estimated $4.2M.
- Paloma Partners first reported a position in State Street Health Care Select Sector SPDR ETF in Q3 2014 and held it in 39 quarters.
- Paloma Partners's State Street Health Care Select Sector SPDR ETF position peaked at $65.5M in Q2 2019.
- 1,647 funds tracked by Wall St. Rank held State Street Health Care Select Sector SPDR ETF as of Q3 2025.
Based on Paloma Partners's 13F filing for Q3 2025, filed 14 Nov 2025.